Strona główna・Stock List・Voyager Therapeutics Inc

Voyager Therapeutics Inc

Closed

3.56

Buy Sell

Overview

Share price change

24h

Current

Min

3.5

Max

3.58

Key metrics
By Trading Economics
Income	-511K -28M
Sales	-13M 2.6M
EPS	-0.47
Profit margin	-1,077.401
Employees	141
EBITDA	1.9M -27M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+373.54% upside

Dividends
By Acuity
Next Earnings	4 sie 2026

Market Stats
By TradingEconomics
Market Cap	-7.2M 227M
Previous open	3.56
Previous close	3.56

Voyager Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

28 cze 2026, 23:51 UTC

Bitcoin dips while Ethereum rises amid investor caution over stock market leverage and upcoming AI earnings reports.

28 cze 2026, 23:51 UTC

Japan's retail sales data reveals consumer spending trends amid rising concerns over stock market leverage and volatility, as investors brace for upcoming U.S. Non-Farm Payrolls report.

28 cze 2026, 23:51 UTC

Bitcoin dips while Ethereum rises amid investor concerns over high leverage and volatility in equity markets, with key U.S. economic data expected to influence market dynamics.

28 cze 2026, 23:51 UTC

Bitcoin dips as Ethereum rises amid concerns over high leverage in stock markets and anticipation of Meta's earnings report, with key economic data releases on July 2 expected to impact Federal Reserve policy.

28 cze 2026, 23:51 UTC

ECB Forum on Central Banking Set for June 29, 2026: Focus on Monetary Policy and Interest Rates Amid Economic Uncertainties.

28 cze 2026, 23:51 UTC

Macro News

Bitcoin is lower as geopolitical tensions rise and South Korean stocks decline. It is currently about 5.32% below its 20-day moving average.

28 cze 2026, 23:41 UTC

Japan's Retail Sales Expected to Rise 3.2% in May, Boosting Investor Confidence Amid Global Market Concerns

28 cze 2026, 23:41 UTC

Avalanche is higher today, continuing its modest gain since Saturday's close. The price has fluctuated within a narrow range during the session.

28 cze 2026, 23:41 UTC

The FTSE 100 Index is lower after market hours, reflecting cautious investor sentiment amid rising concerns over high leverage and increased equity financing costs.

28 cze 2026, 23:32 UTC

Macro News

Correlated Moves

Ethereum is trading lower amid heightened geopolitical tensions and stock market volatility. Earlier in the session, it rebounded from a session high.

28 cze 2026, 23:22 UTC

Market Awaits BoE Governor Bailey's Speech on Interest Rates Amid AI-Driven Financial Stability Concerns.

28 cze 2026, 23:22 UTC

Market Awaits U.S. Average Hourly Earnings Data Amid Wage Legislation Debates and AI Sector Concerns Impacting Federal Reserve Policy.

28 cze 2026, 23:22 UTC

U.S. Labor Force Participation Rate Report Set for July 2, Amid Employee Dissatisfaction and Minimum Wage Legislation Debates

28 cze 2026, 23:22 UTC

Investors Brace for Insights on Interest Rates as BoC Governor Macklem's Speech Approaches Amid Economic Challenges in Canada

28 cze 2026, 23:22 UTC

U.S. Unemployment Rate Expected to Hold Steady at 4.3% Ahead of July 2 Release Amid Employee Dissatisfaction and Potential Minimum Wage Legislation

28 cze 2026, 23:22 UTC

U.S. Non Farm Payrolls Report on July 2 Forecasts 114K Job Additions Amid Cautious Market Sentiment and Legislative Changes Impacting Labor Dynamics.

28 cze 2026, 23:22 UTC

Market Awaits June 2026 Average Hourly Earnings Data Amidst Wage Growth Concerns and Legislative Push for Minimum Wage Increase.

28 cze 2026, 23:12 UTC

Mexico's Consumer Confidence Index set for July 3, 2026 release amid declining sentiment and cautious market expectations.

28 cze 2026, 23:11 UTC

GBP/CHF remains roughly flat during after-market hours, trading within a routine range since Friday's close amid concerns over high leverage in the stock market.

28 cze 2026, 23:11 UTC

SGD/CHF is trading roughly flat in after-market hours, remaining near the upper end of its one-month range amid broader market volatility concerns.

28 cze 2026, 23:11 UTC

Correlated Moves

USD/SEK remains roughly flat in after-market hours amid concerns about high leverage in the stock market and its impact on volatility.

28 cze 2026, 23:11 UTC

Correlated Moves

CHF/HKD trading remains roughly flat during after-market hours amid concerns over high stock market leverage and increased volatility in equity financing costs.

28 cze 2026, 23:01 UTC

Gold and silver prices are trading higher during the ongoing session, remaining above their 20-day moving average and near the upper end of their one-month range.

28 cze 2026, 23:01 UTC

Correlated Moves

Silver/CHF is lower today, following a decline from earlier highs. The asset trades below its 20-day moving average amid shifting market sentiment and increased volatility.

28 cze 2026, 23:01 UTC

Correlated Moves

Silver/GBP is lower today, reflecting declines in correlated assets like gold. Prices have fluctuated notably, currently near the lower end of its one-month range.

28 cze 2026, 23:01 UTC

Macro News

US 10Y Treasury Bond Index advances amid escalating Middle East tensions and lower oil prices, reflecting cautious investor sentiment near the upper trading range.

28 cze 2026, 23:01 UTC

The US 5Y Treasury Bond Index is trading higher, reflecting increased activity. It remains near the upper end of its one-month trading range.

28 cze 2026, 23:01 UTC

Macro News

Tensions between the U.S. and Iran have reportedly eased, potentially influencing global oil markets. The US 2Y Treasury Bond Index is trading roughly flat.

28 cze 2026, 23:01 UTC

Correlated Moves

Silver/SGD is trading lower, reflecting a challenging market environment and notable volatility. The asset remains significantly below its 20-day moving average.

28 cze 2026, 23:01 UTC

Correlated Moves

Silver/JPY is lower today, reflecting notable volatility and trading near the lower end of its one-month range. The asset is approximately 9.98% below its 20-day moving average.

Peer Comparison

Price change

Voyager Therapeutics Inc Forecast

Price Target

By TipRanks

373.54% upside

12 Months Forecast

Average 17 USD 373.54%

High 25 USD

Low 8 USD

Based on 6 Wall Street analysts offering 12 month price targets forVoyager Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

Buy

Hold

Sell

Based on 6 analysts giving stock ratings to Voyager Therapeutics Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Voyager Therapeutics Inc

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.